Compare First Citizens BancShares Inc (FCNCA) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Citizens BancShares Inc vs 22nd Century Group Inc — how do they compare? First Citizens BancShares Inc trades at $2,068.39 (market cap $22.94B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: First Citizens BancShares Inc is far larger — about 36900.6× 22nd Century Group Inc's market cap, and First Citizens BancShares Inc pays a 0.41% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold First Citizens BancShares Inc for 29 Days and 22nd Century Group Inc for 32 Days on average.
| FCNCA | XXII | |
|---|---|---|
Market Cap | $22.94B | $621.67K |
Volume | 91,668 | 45,625 |
Sector | Sector/Thematic | Consumer Staples |
52-Week High | $2.29K | $483.00 |
52-Week Low | $1.64K | $0.80 |
Typical Hold Time | 29 Days | 32 Days |
Dividend Yield | 0.41% | — |
Enterprise Value | — | -$3.69M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
First Citizens BancShares (FCNCA) trades at $2,065.89, down slightly (-0.27%) with a bearish technical outlook. The company demonstrates strong fundamental performance with consistent earnings beats (Q2 2026 EPS of $57.09 vs. $40.69 expected) and robust profitability (25.23% net margin). Recent developments include branch expansions and significant commercial lending activity, though cash flow trends show heavy investment outflows. Analyst sentiment is cautious with 82% hold ratings despite a $2,290 consensus price target suggesting modest upside potential.
FCNCA presents a mixed investment case with solid fundamentals offset by technical weakness and cautious analyst sentiment. The stock offers value characteristics with an 11.08 P/E ratio and dividend income, but faces headwinds from bearish technical indicators and institutional selling pressure. Key risks include execution of expansion strategy and potential margin compression in a competitive banking environment.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
